A novel platelet concentrate for guided bone regeneration: Titanium Prepared Platelet-Rich Fibrin (T-PRF):
PDF
Cite
Share
Request
Original Article
P: 102-106
June 2015

A novel platelet concentrate for guided bone regeneration: Titanium Prepared Platelet-Rich Fibrin (T-PRF):

Gulhane Med J 2015;57(2):102-106
1. Department of Periodontology, Gulhane Military Medical Academy, Haydarpaşa Training Hospital, Istanbul, Turkey.
2. Department of Periodontology, School of Dentistry, Osmangazi University, Eskisehir, Turkey.
3. Department of Medical Pathology, Gulhane Military Medical Academy, Haydarpaşa Training Hospital, Istanbul, Turkey.
4. Department of Oral Surgery, School of Dentistry, Bezmialem Vakif University, Istanbul, Turkey.
5. Department of Oral Pathology, School of Dentistry, Gazi University, Ankara, Turkey.
6. Department of Prosthetic Dentistry, School of Dentistry, Selcuk University, Konya, Turkey .
7. Department of Prosthetic Dentistry, Gulhane Military Medical Academy, Haydarpaşa Training Hospital, Istanbul, Turkey.
8. Department of Periodontology, School of Dentistry, Istanbul University, Istanbul, Turkey
No information available.
No information available
Received Date: 25.11.2014
Accepted Date: 22.02.2015
Publish Date: 30.06.2015
PDF
Cite
Share
Request

ABSTRACT

In our previous studies, we developed a novel platelet-rich product that we called titaniumprepared platelet-rich fibrin (T-PRF). T-PRF is based on the hypothesis that titanium may be more effective at activating platelets than the silica activators used with glass tubes in Chouckroun's platelet-rich fibrin (PRF). This study aimed to assess the effects of T-PRF on bone augmentation in a rabbit calvaria model. Twenty-four adult male New Zealand rabbits were used in the study. T-PRF alone, inorganic bovine bone (ABB), and T-PRF + ABB were used in the experimental groups. No material was used in the control group. Half of the animals were sacrificed after one month, and the remaining animals were sacrificed 3 months later. A histomorphometric evaluation was performed to compare new bone formation among the groups. More new bone areas were determined in the T-PRF group than the other three groups. While less new bone formation was observed than in the T-PRF group, more new bone formation occurred in the ABB and T-PRF + ABB groups when compared to the control group. Basing on the results of this study, we can say that T-PRF membrane can be successfully used for bone augmentation.